Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal neostigmine for prevention of post-dural puncture headache after cesarean section
PACTR202203682996126Phase 4Recruiting
- Sponsor
- Alexandria University Hospital
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of neostigmine in post-dural puncture headache (PDPH) (2 arms), sponsored by Alexandria University Hospital. Primary endpoint: Incidence of post-dural puncture headache. Started Apr 2022; status: recruiting.
02
Drugs
neostigmine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on PACTR202203682996126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202203682996126.